R Todd Ogden Selected Research

R Todd Ogden Research Topics

22	Major Depressive Disorder (Major Depressive Disorders) 08/2022 - 01/2006
6	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 02/2007
1	Mood Disorders (Mood Disorder) 12/2022
1	Ascites 01/2021
1	Parkinson Disease 16 01/2021
1	Alcoholism (Alcohol Abuse) 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Cognitive Dysfunction 01/2017
1	Dementia (Dementias) 01/2017
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 08/2015
1	Stroke (Strokes) 01/2015
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 03/2013
1	Brain Diseases (Brain Disorder) 03/2013
1	Mental Disorders (Mental Disorder) 07/2009
1	Alzheimer Disease (Alzheimer's Disease) 04/2008
1	Schizophrenia (Dementia Praecox) 04/2008

11	Serotonin (5 Hydroxytryptamine)IBA 08/2022 - 01/2006
9	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 08/2022 - 01/2006
8	5-HT1A Serotonin ReceptorIBA 12/2022 - 11/2013
6	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 01/2019 - 08/2009
4	Antidepressive Agents (Antidepressants)IBA 01/2022 - 07/2013
3	Biomarkers (Surrogate Marker)IBA 10/2018 - 03/2013
3	AutoreceptorsIBA 01/2018 - 03/2013
2	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2022 - 01/2019
2	LigandsIBA 01/2021 - 07/2014
2	Ketamine FDA LinkGeneric 01/2020 - 08/2015
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 02/2007 - 01/2006
1	LipopolysaccharidesIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA 01/2021
1	LithiumIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2019
1	Glutamic Acid (Glutamate)FDA Link 08/2015
1	gamma-Aminobutyric Acid (GABA)IBA 08/2015
1	Glutamine (L-Glutamine)FDA Link 08/2015
1	CarbonIBA 02/2015
1	Escitalopram FDA Link 11/2013
1	Serotonin 5-HT1 Receptor AntagonistsIBA 03/2013
1	Biological ProductsIBA 07/2009
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 10/2008
1	McN 5652IBA 01/2006

1	Transcranial Magnetic Stimulation 01/2015